NTRA

Q: What is the price of Natera (NTRA) today?

The current price of Natera (NTRA) is $234.76. The stock began the year trading around $229.09 and is currently priced at $234.76. You can follow the real-time price chart, review historical performance, and track broader market trends directly on the platform.

Q: When does Natera (NTRA) pay dividends?

Natera (NTRA) did not pay dividends over the past year.

Q: Is Natera (NTRA) a good investment?

Natera (NTRA) is currently trading at $234.76 with a P/E ratio of -145.20. This represents a -8,630% premium compared to its historical average P/E. Over the past year, the stock paid $0.00 in dividends, resulting in a dividend yield of 0.00%. The total shareholder return over the same period was 37.79%.Investors should keep in mind that past performance does not guarantee future results. This information is provided for educational purposes only and should not be considered investment advice.

Natera Inc.

Price

$234.76

return (12m)

37.79%

p/e

-145.20

p/bv

18.52

DIVIDEND YIELD

0.00%

NTRA price

Natera

If you had invested

exposure

years ago

7 days

30 days

6 months

YTD

1 year

5 years

10 years

15 years

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment NTRA

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

15.54%

3 months

18.94%

1 year

37.79%

2 years

119.18%

5 years

96.09%

10 years

0.00%

Fundamentals NTRA

review the fundamentals of Natera shares

P/E

-145.20

Sector: -3.91 Industry: -3.91

P/S (PSR)

13.14

Sector: -4.11 Industry: -4.11

P/BV

18.52

Sector: 1.95 Industry: 1.95

DIVIDEND YIELD (DY)

0.00%

Sector: - Industry: -

ROA

-8.66%

Sector: -65.76% Industry: -65.76%

ROE

-12.76%

Sector: -65.99% Industry: -65.99%

ROIC

-31.46%

Sector: -2,915.77% Industry: -2,915.77%

NET MARGIN

-9.05%

Sector: -40.24% Industry: -40.24%

GROSS MARGIN

65.07%

Sector: 36.75% Industry: 36.75%

OPERATING MARGIN

-12.97%

Sector: -39.10% Industry: -39.10%

EV/EBITDA

-144.31

Sector: -4.01 Industry: -4.01

EV/EBIT

-116.45

Sector: -4.09 Industry: -4.09

PRICE-TO-ASSETS

12.57

Sector: 1.44 Industry: 1.44

BVPS

12.49

Sector: 1.85 Industry: 1.85

EPS

-1.59

Sector: -2.14 Industry: -2.14

EQUITY-TO-ASSETS RATIO

0.68

Sector: 0.42 Industry: 0.42

LIABILITIES / ASSETS

0.32

Sector: 0.40 Industry: 0.40

CAGR REVENUE 5 YEARS

31.94%

Sector: - Industry: -

CAGR PROFIT 5 YEARS

-13.66%

Sector: - Industry: -

Fundamentals NTRA

DRAG THE FRAME TO SEE MORE DATA

Stock Comparison Tool

DRAG THE FRAME TO SEE MORE DATA

	p/e	p/bv	ROE	dy	market cap	net margin
JNJ	26.15	6.78	25.92%	2.29%	$550.19 B	21.83%
PFE	19.15	1.59	8.29%	6.82%	$143.47 B	11.83%
ABBV	104.57	-57.49	-54.98%	3.14%	$380.13 B	5.79%
NVO	11.11	6.71	60.40%	3.92%	$210.69 B	37.15%
MRK	31.50	6.13	19.45%	2.92%	$281.49 B	13.59%
AZN	26.08	5.72	21.93%	1.83%	$270.97 B	17.19%
GILD	16.57	6.52	39.33%	2.59%	$152.71 B	30.99%
BMY	15.13	5.47	36.19%	4.63%	$110.05 B	15.01%
ZTS	12.57	10.27	81.75%	2.62%	$33.22 B	27.79%
REGN	14.34	2.02	14.08%	0.60%	$63.43 B	29.65%
HALO	23.19	36.83	158.82%	0.00%	$8.09 B	23.13%
AMGN	23.37	19.84	84.87%	2.90%	$182.30 B	20.96%
MCK	19.23	-109.80	-570.98%	0.42%	$91.58 B	1.18%
VRTX	26.44	5.92	22.41%	0.00%	$114.71 B	35.51%
HRMY	13.25	2.12	16.00%	0.00%	$1.93 B	16.20%
CAH	33.52	-19.50	-58.20%	0.92%	$52.12 B	0.62%
BIIB	21.06	1.55	7.36%	0.00%	$28.90 B	13.81%

Stock vs Indice Comparison Tool

If you had invested

years ago

2 years

5 years

10 years

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

NTRA Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT Natera

Natera Inc.

Average Investor10 user rating

4.0 (9 people)

United States

19 years

Founded: 2007

2015

Time since IPO - 11 years

1.815

Employees

Natera Inc. (United States) is listed on the Nasdaq and has a market capitalization of $32.86 billion, with shareholders equity totaling $1.77 billion.

The company employs approximately 1.815 people and operates in the Health Care sector, within the Biotechnology industry.

Over the past 12 months, Natera Inc. reported $2.50 billion in revenue, generating net income of $-226.31 million.

Key financial metrics include a P/E ratio of -145.20, a price-to-book (P/B) ratio of 18.52, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker NTRA.

Market cap

$32.86 billion

Net worth

$1.77 billion

$1,774,020,000.00

Assets

$2.61 billion

$2,614,400,000.00

Total Shares Outstanding

142.00 million

142,000,000

Average Daily Trading Volume

$1.52 million

$1,515,182.00

Sector

Health Care

Industry

Biotechnology

NTRA

revenue by Business Segment Natera

Revenue by Region Natera

NTRA revenue and profits

Financial Results NTRA

DRAG THE FRAME TO SEE MORE DATA

NTRA cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

BFRA - Biofrontera

$- -0,00% (12M)

P/E

0.00

0.00%

ROE

-893.55%

P/BV

0.00

MCK - McKesson

$763.91 6,51% (12M)

P/E

19.23

0.42%

ROE

-570.98%

P/BV

-109.80

CAH - Cardinal Health

$228.91 41,32% (12M)

P/E

33.52

0.92%

ROE

-58.20%

P/BV

-19.50

JNJ - Johnson & Johnson

$239.08 61,04% (12M)

P/E

26.15

2.29%

ROE

25.92%

P/BV

6.78

MRK - Merck & Co.

$119.60 55,38% (12M)

P/E

31.50

2.92%

ROE

19.45%

P/BV

6.13

AZN - AstraZeneca

$181.02 32,17% (12M)

P/E

26.08

1.83%

ROE

21.93%

P/BV

5.72

ABBV - AbbVie

$234.76 31,68% (12M)

P/E

104.57

3.14%

ROE

-54.98%

P/BV

-57.49

NVO - Novo Nordisk

$47.42 --26,19% (12M)

P/E

11.11

3.92%

ROE

60.40%

P/BV

6.71

BFRA - Biofrontera

$- -0,00% (12 M)

P/L

0.00

0.00%

ROE

-893.55%

P/VP

0.00

MCK - McKesson

$763.91 6,51% (12 M)

P/L

19.23

0.42%

ROE

-570.98%

P/VP

-109.80

CAH - Cardinal Health

$228.91 41,32% (12 M)

P/L

33.52

0.92%

ROE

-58.20%

P/VP

-19.50

JNJ - Johnson & Johnson

$239.08 61,04% (12 M)

P/L

26.15

2.29%

ROE

25.92%

P/VP

6.78

MRK - Merck & Co.

$119.60 55,38% (12 M)

P/L

31.50

2.92%

ROE

19.45%

P/VP

6.13

AZN - AstraZeneca

$181.02 32,17% (12 M)

P/L

26.08

1.83%

ROE

21.93%

P/VP

5.72

ABBV - AbbVie

$234.76 31,68% (12 M)

P/L

104.57

3.14%

ROE

-54.98%

P/VP

-57.49

NVO - Novo Nordisk

$47.42 --26,19% (12 M)

P/L

11.11

3.92%

ROE

60.40%

P/VP

6.71

Frequently Asked Questions

What is the price of Natera (NTRA) today?

The current price of Natera (NTRA) is $234.76. The stock began the year trading around $229.09 and is currently priced at $234.76. You can follow the real-time price chart, review historical performance, and track broader market trends directly on the platform.

When does Natera (NTRA) pay dividends?

Natera (NTRA) did not pay dividends over the past year.

Is Natera (NTRA) a good investment?

Natera (NTRA) is currently trading at $234.76 with a P/E ratio of -145.20. This represents a -8,630% premium compared to its historical average P/E. Over the past year, the stock paid $0.00 in dividends, resulting in a dividend yield of 0.00%. The total shareholder return over the same period was 37.79%.

Investors should keep in mind that past performance does not guarantee future results. This information is provided for educational purposes only and should not be considered investment advice.

How can I buy Natera (NTRA) stock?

You can buy Natera (NTRA) shares through any brokerage account that provides access to U.S. stock exchanges. After opening and funding your account, simply search for the ticker symbol NTRA and place a buy order. Before investing, consider factors such as your financial goals, risk tolerance, and overall portfolio allocation.

How much would 100 shares of Natera (NTRA) yield today?

Over the past month, Natera (NTRA) has returned 15.54% — 37.79% over the past year, and 96.09% over the past five years, including price appreciation and dividends.

In the last 12 months, the company paid a total of 0.00 per share in dividends, resulting in a dividend yield of 0.00%.

If you were to purchase 100 shares of Natera (NTRA) today at the current price of $234.76 your total investment would be $23,476.00.

Based on historical performance, the investment would have grown to approximately:

$32,347.58 after 1 year
$46,034.09 after 5 years
$23,476.00 after 10 years

Past performance does not guarantee future results. This content is for informational purposes only and should not be considered investment advice.

NTRA

Natera Inc.

Price

return (12m)

p/e

p/bv

DIVIDEND YIELD

Return on Investment NTRA

review the fundamentals of Natera shares

P/E

P/S (PSR)

P/BV

DIVIDEND YIELD (DY)

ROA

ROE

ROIC

NET MARGIN

GROSS MARGIN

OPERATING MARGIN

EV/EBITDA

EV/EBIT

PRICE-TO-ASSETS

BVPS

EPS

EQUITY-TO-ASSETS RATIO

LIABILITIES / ASSETS

CAGR REVENUE 5 YEARS

CAGR PROFIT 5 YEARS

current DY: 0.00%

5-year average DY: 0.00%

ABOUT Natera

Natera Inc.

United States

19 years

2015

1.815

PROFIT X PRICE NTRA

Financial Results NTRA

NTRA cash flow

Asset, Revenue and Profit Growth - NTRA

NTRA balance sheet

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

MRK - Merck & Co.

AZN - AstraZeneca

ABBV - AbbVie

NVO - Novo Nordisk

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

MRK - Merck & Co.

AZN - AstraZeneca

ABBV - AbbVie

NVO - Novo Nordisk

Frequently Asked Questions